Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-29 @ 11:48 PM
Study NCT ID:
NCT05817903
Status:
RECRUITING
Last Update Posted:
2023-05-08
First Post:
2023-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients
Sponsor:
Consorzio Oncotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-14
First Submit QC Date:
None
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-05
Last Update Post Date:
2023-05-08
Last Update Post Date Type:
ACTUAL